Here's a selection of information from patients & professionals to better understand Atypical Hemolytic Uremic Syn..
Atypical Hemolytic Uremic Syn. resources
Atypical Hemolytic Uremic Syn. Frequently Asked Questions
Here are some of the most frequently asked questions and their answers:
If you are a patient or carer with a question about living with aHUS, about treatments, or other relevant information please email your question to [email protected] and we will put it to the specialists who have agreed to answer your questions from time to time.
When should one consider testing for aHUS?
Atypical HUS is considered genetic when two or more members of the same family are affected by the disease at least six months apart and exposure to a common triggering infectious agent has been ex...
What happens to the body during an aHUS attack?
With aHUS the red blood cells break apart and these cell fragments travel to the kidneys, making tiny microscopic clots causing severe anemia and kidney failure. When the kidneys fail to work, the ...
What is aHUS?
Atypical Hemolytic-uremic syndrome (aHUS) is a syndrome characterized by three major problem areas:
1) progressive renal failure
2) problems associated with red blood cell and platelet counts...
Atypical Hemolytic Uremic Syn. Patient Groups
These are patient organisations that have experience and expertise in Atypical Hemolytic Uremic Syn.. They are supporters of this website. Contact them for more information on their activities.
-
Foun. Children with aHUS
The Foundation for Children with Atypical HUS encourages patients and investigators to share information and explore options/resources as we work together to gain insight into this rare complement disorder. By increasing contact opportunities with researchers and medical personnel interested in helping the aHUS community, our stories foster a better understanding of atypical hemolytic uremic syndrome. Sharing information, inspiration and support for one another, we seek to gather together people and knowledge as we strive to improve the lives of patients and families dealing with a diagnosis of aHUS.
Contact Foun. Children with aHUS -
AIRG
Association for Information and Research on Genetic Renal Diseases The AIRG organization is present in France, Spain, Switzerland, Belgium. AIRG aims to bring together patients and their families who suffer from genetic kidney disease. Together we are stronger.
Contact AIRG
Atypical Hemolytic Uremic Syn. Documents
Resources, documents and detailed informations on Atypical Hemolytic Uremic Syn.. In this section you can download brochures, ask for printed documents or find useful links.
-
aHUS: The Situation in 2011
Article in French language, courtesy of AIRG France
Author/Foundation: Chantal LOIRAT, Fadi FAKHOURI, et al.
Year of publication: 2011, French
-
3rd International Conference Program HUS & MPGN & related diseases
Current diagnosis and therapy of hemolytic uremic syndrome (HUS) membranoproliferative glomerulonephritis (MPGN) and related diseases Program includes poster descriptions.
Author/Foundation: www.hus-online.at
Year of publication: 2011, English
-
AHCF NEWSLETTER Alternating Hemiplegia of Childhood Foundation SPRING 2011 Volume 20, No. 1
Author/Foundation: AHC Foundatiom
Year of publication: 2011, English
-
Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome
Abstract: This case report describes how eculizumab reversed neurologic impairment and improved renal damage in severe atypical hemolytic uremic syndrome. A 50-year-old female, after presenting with diarrhea and abdominal pain, developed pancolitis, acute renal failure, and thrombocytopenia. The patient underwent total abdominal colectomy. Pathology confirmed ischemic colitis with scattered mesenteric microthrombi. Due to mental and respiratory decline, she remained intubated. Continuous venovenous hemodialysis was initiated. Renal failure, neurologic changes, hemolysis, thrombotic microangiopathy, and low complement levels all suggested atypical hemolytic uremic syndrome. Eculizumab 900 mg was administered intravenously on hospital day 6 and continued weekly for four doses followed by maintenance therapy. She recovered neurologically and renally after the third dose, and hematologically by the sixth dose. Her recovery has been sustained on long-term eculizumab treatment. In severe atypical hemolytic uremic syndrome, eculizumab safely reverses neurologic impairment and eliminates the need for dialysis. The optimal duration of treatment with eculizumab remains to be determined.
Author/Foundation: Maro Ohanian, Christian Cable, Kathleen Halka
Year of publication: 2011, English
-
A Parent's Perspective - aHUS BOOTCAMP
You or your child have been diagnosed with Atypical HUS - Now What? Originally published online here: http://www.atypicalhus.org/page/a-parents-perspective-ahus
Author/Foundation: Cheryl Biermann, Linda Burke, and Jodi Kayler
Year of publication: 2010, English
Atypical Hemolytic Uremic Syn. Articles
Most recent articles:
A Parent's Perspective - aHUS BOOTCAMP
So, you or your child's symptoms have lead you to the doctor or straight to the hospital. Symptoms may have included extreme fatigue, puffiness, vomiting, paleness, fever, and perhaps some diar...
NORD article on Atypical HUS
Atypical Hemolytic Uremic Syndrome
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web s...
aHUS, What is the Situation in 2011 (French language)
Le syndrome hémolytique et urémique (SHU), caractérisé par l’association d’une anémie hémolytique avec schizocytes, d’une thrombopé...
Atypical Hemolytic Uremic Syn. Events
Most recent events:
-
October 2011
-
AIRG France Annual Meeting
On 15 October 2011
October 15, 2011 in Montpellier, Faculty of Medicine School of Medicine, 2 Rue 34000 Montpellier
-
AIRG Belgique: Journée Annuelle
On 23 October 2011
A vos agendas, notre prochaine journée annuelle est prévue le 23 octobre 2011 à Namur.
-
December 2011
-
International Day of Persons with Disabilities
On 3 December 2011
The annual observance of the International Day of Persons with Disabilities on 3 December was established by the International Year for Disabled Persons (1981). The Day aims to promote a better understanding of disability issues with a focus on the rights of persons with disabilities and gains to be derived from the integration of persons with disabilities in every aspect of the political, social, economic and cultural life of their communities. The goal of full and effective participation of persons with disabilities in society and development was established by the World Programme of Action concerning Disabled Persons, adopted by the United Nations General Assembly in 1982.
-
February 2012
-
RE (ACT) Congress
From 28 February to 2 March 2012
International Congress on Research of Rare and Orphan Diseases Basel, Switzerland